A Phase II, Multicenter, Single-Arm Clinical Trial of Definitive Radiotherapy And CeMiPlimAb-Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: RAMPART
Details
Age
Adult
Type of Study
Treatment
Locations
Highlands Ranch Hospital
University of Colorado Hospital
Principal Investigator
Ryan Lanning, MD, PhD
Study ID
Protocol Number: 22-1922
More information available at ClinicalTrials.gov: NCT05574101
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers